BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sridhar GR. Can the management of depression in type 2 diabetes be democratized? World J Diabetes 2022; 13(3): 203-212 [PMID: 35432759 DOI: 10.4239/wjd.v13.i3.203]
URL: https://www.wjgnet.com/2220-3206/full/v13/i3/203.htm
Number Citing Articles
1
Mohammad Ali Bayani, Azade Talebnia Roshan, Sussan Moudi, Hemmat Gholinia Ahangar. Sertraline and Fluoxetine in Adult Patients with Comorbid Depression and Type II Diabetes Mellitus: A Randomized Controlled TrialJundishapur Journal of Chronic Disease Care 2023; 13(1) doi: 10.5812/jjcdc-138454
2
Hans-Peter Kapfhammer. Depression, Angst, traumatischer Stress und internistische Erkrankungen2022; : 221 doi: 10.1007/978-3-662-65873-4_4
3
G. R. Sridhar, G. Lakshmi. Editorial: Diabetes and depressionFrontiers in Clinical Diabetes and Healthcare 2023; 4 doi: 10.3389/fcdhc.2023.1221640
4
Je-Yeon Yun, Young Ho Yun. Health-promoting behavior to enhance perceived meaning and control of life in chronic disease patients with role limitations and depressive symptoms: a network approachScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-31867-3
5
Muhammad Aaqib Shamim, Ravindra Shukla, Mukesh Kumar Swami, Shival Srivastav, Anindita Pradhan, Suraj Singh Yadav, Abhishek Anil, Aswini Saravanan, Shoban Babu Varthya, Surjit Singh, Pradeep Dwivedi. Targeting self-care adherence for glycaemic control in multimorbid type 2 diabetes mellitus with depression using bupropion: a protocol for cross-over randomised controlled trialBMJ Open 2024; 14(6): e077975 doi: 10.1136/bmjopen-2023-077975
6
Hesham Abuhegazy, Ahoud Mujairi, Faisal Banah, Yasir Agdi, Heba Elkeshishi, Ahmed Kamel, Ahmed Abdullah, Mohamed Elsheikh. Depression and Associated Risk Factors Among Type 2 Diabetic Patients: A Cross Sectional Study on a Convenience Sample from the Diabetic Center, Khamis Mushait; Saudi ArabiaNeuropsychiatric Disease and Treatment 2022; : 1975 doi: 10.2147/NDT.S374752